Clinical and computerized EEG effects of U-31,920, a new anxiolytic.
D000328:Adult; D000498:Allyl Compounds / Q000627:therapeutic use; D000704:Analysis of Variance; D001007:Anxiety / Q000188:drug therapy*; D001552:Benzazepines / Q000627:therapeutic use*; D001569:Benzodiazepines; D002986:Clinical Trials as Topic; D003201:Computers; D003975:Diazepam / Q000627:therapeutic use; D004569:Electroencephalography; D005260:Female; D006801:Humans; D006898:Hydroxylamines / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D000498:Allyl Compounds; D001552:Benzazepines; D006898:Hydroxylamines; D010919:Placebos; D014149:Tranquilizing Agents; D001569:Benzodiazepines; D003975:Diazepam; C006295:uldazepam